Aquablation Therapy

This innovative procedure is the only real-time, ultrasound-guided, robotic-assisted, heat-free water jet to treat BPH. It treats an enlarged prostate of any shape and size, providing long-lasting relief and improving urine flow with fewer side effects than other treatment options. 

Meet Howard: A Journey from Struggle to Relief with Aquablation Therapy

Aquablation therapy is performed in the hospital. Patients are under anesthesia for the entire procedure, which typically takes an hour and may involve an overnight stay. It is a resective procedure, which means the prostate tissue causing symptoms is surgically removed. There are no incisions. The prostate is reached by going through the urethra. 

Every prostate is unique in size and shape. This procedure enables urologists to customize the therapy to fit specific anatomy. 

There are two steps:

1. Creating a surgical map
   During surgical planning, urologists use ultrasound imaging, with a camera (called a cystoscope), to create a detailed guide for planning the procedure. This real-time visualization allows urologists to map which parts of the prostate to remove and which parts to avoid, decreasing complications like erectile dysfunction, ejaculatory dysfunction, and incontinence. 
   
   

    

2. Removing the prostate tissue
   Once urologists create a surgical map, a robotic-assisted system follows the surgical plan and resects the targeted prostate tissue using a heat-free water jet. This advanced technology helps ensure precise tissue removal. 
   
   

Aquablation therapy is a different kind of surgical procedure, with several benefits. Consult your urologist to determine if you're a good candidate.

Fewer Complications
Aquablation therapy is associated with very low rates of permanent complications (incontinence, ejaculatory dysfunction, erectile dysfunction) because: ^1-2

• It is the only procedure that gives urologists the ability to view the entire prostate, enabling them to create a map that avoids the parts of the prostate that cause irreversible complications.
• It is the only procedure that uses a heat-free water jet to remove prostate tissue, minimizing human error. Technologies that use heat to remove prostate tissue may be damaging to the parts of the prostate that control erectile function and ejaculatory function. Urologists may use a minimal amount of cautery following an Aquablation therapy procedure to control bleeding.

Long-Term Relief
In clinical studies, Aquablation therapy provides long-term relief at 5 years.^1,2

Exceptional results vs TURP
When compared with transurethral resection of the prostate (TURP), Aquablation therapy demonstrated:⁵

• Similar symptom relief
• Lower complication rates
• Fewer retreatments

Take the International Prostate Symptom Score (IPSS) Quiz to measure symptom severity.

Take the Sexual Function Quiz to help determine if maintaining sexual function after BPH surgery is important to you.

To make an appointment, call 757-457-5100.

Read important safety information.

As with most BPH procedures, patients will wake up with a catheter following surgery, which allows them to urinate while their urethra heals. The procedure may involve an overnight stay in the hospital. The benefit of Aquablation therapy is that most patients can leave the hospital without a catheter.^1,2,4
 
For more information, visit the Aquablation website.

In clinical studies, men who had Aquablation therapy experienced very few irreversible complications, such as incontinence, ejaculatory dysfunction and erectile dysfunction.³

For more information, visit the Frequently Asked Questions section at Aquablation.com.

To make an appointment, call 757-457-5100.

REFERENCES

1. Gilling PJ et al. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol. 2022 Feb;29(1):10960-10968. 
2. Bhojani N, et al. Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results. J Urol. 2023;210(1):143-153.
3. Elterman D, et al. BMJ Surg Interv Health Technol. 2021
4. Data on file at PROCEPT BioRobotics.
5. Oumedjbeur K, et al. Can J Urol. 2023.